SPINK5 and head and neck squamous cell carcinoma: Similar to the case in esophageal cancer, SPINK5 is downregulated in 85.7% of head and neck squamous cell cancer (HNSCC) cases and is an independent prognostic predictor for HNSCC patients (140–143).